Basket | Login | Register

 
 
 
 

2006 Accounts

Financial accounts


Balance sheet as of December 31, 2006

 

2006 (Euro)

2005 (Euro)

     

ASSETS

     

Current assets

Debtors

10,229

40,141

Subsidies due (EC)

10,363

 

Cash at bank and on deposit

141,014

100,616

 

161,606

140,757

     

Accruals

354

120

 

161,960

140,877

     

LIABILITIES

   
     

Capital and reserves

   

Results brought forward

73,445

83,745

Result of the year

16,724

- 10,300

 

90,169

73,445

     

Creditors

   

Payments received on account

45,557

30,000

Trade creditors

15,660

20,172

Other liabilities

10,573

17,260

 

71,790

67,432

     

Accruals

   
 

161,960

140,877


Profit and loss account – Year ended December 31, 2006

 

2006 (Euro)

2005 (Euro)

Support and revenue

   
     

Subsidies from the EC

233,270

 
     

Other operating income

   

Co-financing in kind

203,155

114,885

Corporate sponsorship

183,176

165,415

Sponsorship received on account

45,557

 

AE Conference

58,597

10,000

Membership fees

41,250

40,000

Other sponsorship/Subsidies

24,325

6,391

Publication sales and royalties

7,059

12,012

Other operating revenue

6,120

4,834

Internet services

5,815

5,925

Donations

57

1,500

     

External charges

   

External experts

- 335,668

- 119,591

AE Conference

- 53,558

 

Travel & Accommodation

- 93,586

- 60,170

Publication and Information material

- 29,629

- 19,859

Other costs

- 24,307

- 574

Office rent and associated costs

- 22,291

- 22,887

Communication costs

- 19,473

- 17,828

Equipment & Leasing

- 8,363

- 13,248

Office stationery and related costs

- 2,692

- 1,810

Membership fees

- 750

- 700

Irrecoverable debt

 

- 937

     
     

Staff costs

   

Wages and salaries

- 85,491

- 88,670

Social security costs

- 23,324

- 24,322

     

Interest receivable and similar income

974

581

     

Interest payable and similar charges

- 2,387

- 1,247

     
     
 

16,724

-10,300


Declaration of interests

Platinum donors and sponsors (Donations and sponsorship from €50,000)

Alzheimer Europe is grateful to Association Luxembourg Alzheimer and the Luxembourg Ministry for Family for the secondment of the Executive Director of Alzheimer Europe and the office space they make available to the organisation free of charge.

Gold donors and sponsors (Donations and sponsorship between €20,000 and €49,999)

Alzheimer Europe is grateful to GlaxoSmithKline, Janssen-Cilag, Lundbeck and Pfizer which generously agreed to support the activities Alzheimer Europe carried out in the framework of its business plan in 2006.

Furthermore, Alzheimer gratefully acknowledges the support it has received from Lundbeck for the organisation of a carers’ survey in France, Germany, Poland, Scotland and Spain and from GlaxoSmithKline for the support of delegates to the AE conference in Paris and a workshop on the company’s research activities in the Alzheimer’s field.

Silver donors and sponsors (Donations and sponsorship between €5,000 and €19,999)

Alzheimer Europe gratefully acknowledges the support of Numico for its contribution to the European Parliament event of Alzheimer Europe and for the organisation of a workshop on the company’s research activities in the Alzheimer’s field.

Alzheimer Europe is grateful for the generous contribution of Fondation Médéric Alzheimer to the Eurocode project of Alzheimer Europe.

Alzheimer Europe is grateful to Novartis and Merck Sharp & Dohme for their support to the activities of Alzheimer Europe.

Bronze donors and sponsors (Donations and sponsorship between €1,000 and €4,999)

Alzheimer Europe is grateful to Mazars for having carried out the audit of the 2005 financial accounts of the organisation free of charge.

Support from corporate sponsors

In 2006, Alzheimer Europe had an audited income of 763,798€. Sponsorship by the pharmaceutical industry and other corporate sponsors amounted to 183,176€ or 23.98%. The following table lists sponsorship and donations received by individual companies, as well as other payments, such as speakers’ fees, honoraria and support for travel or subsistence costs. The global support received from individual companies is also presented in terms of percentages of the overall income of the organisation in line with the policy of the European Medicines Agency with regard to the transparency requirements for patients’ organisations.

Company

Sponsorship and donations

Other payments

TOTAL

% of AE income

Lundbeck

30,000€

12,224€

42.224€

5.53%

Janssen-Cilag

40,000€

 

40,000€

5.24%

Pfizer

35,000€

1,361€

36,361€

4.76%

GlaxoSmithKline

25,000€

1,300€

26,300€

3.44%

Novartis

15,000€

1,723€

16,723€

2.19%

Merck Sharp & Dohme

7,891€

 

7,891€

1.03%

APIFARMA

 

1,529€

1,529€

0.20%

EFPIA

 

744€

744€

0.10%

Roche

 

319€

319€

0.04%

Drug Information Association

 

158€

158€

0.02%

Sub-total: Support by the pharmaceutical industry

172.249€

22.55%

Numico

10,000€

 

10,000€

1.31%

GE Healthcare

 

927€

927€

0.12%

Sub-total: Support by other corporate sponsors

10,927€

1.43%

Total: Support by corporate sponsors

183,176€

23.98%

 

 

Downloads

 

 

Last Updated: Wednesday 19 January 2011

 

 
 

Options